Patents by Inventor Hyun Yong Koh

Hyun Yong Koh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12364776
    Abstract: The present invention relates to a biomarker of epilepsy, a composition for diagnosing epilepsy, an epilepsy-induced animal, and a composition for preventing or treating epilepsy, and specifically, relates to a composition for diagnosing epilepsy comprising a BRAF mutant protein and a nucleic acid molecule, and an agent capable of detecting the protein or nucleic acid molecule, an epilepsy-induced animal transformed with the BRAF mutant nucleic acid molecule, and a composition for prevention or treatment of epilepsy comprising a BRAF mutant protein activity inhibitor.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: July 22, 2025
    Assignees: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY, YONSEI UNIVERSITY, UNIVERSITY—INDUSTRY FOUNDATION (UIF)
    Inventors: Jeong Ho Lee, Hyun Yong Koh, Dong Seok Kim
  • Publication number: 20200360537
    Abstract: The present invention relates to a biomarker of epilepsy, a composition for diagnosing epilepsy, an epilepsy-induced animal, and a composition for preventing or treating epilepsy, and specifically, relates to a composition for diagnosing epilepsy comprising a BRAF mutant protein and a nucleic acid molecule, and an agent capable of detecting the protein or nucleic acid molecule, an epilepsy-induced animal transformed with the BRAF mutant nucleic acid molecule, and a composition for prevention or treatment of epilepsy comprising a BRAF mutant protein activity inhibitor.
    Type: Application
    Filed: June 26, 2018
    Publication date: November 19, 2020
    Inventors: Jeong Ho LEE, Hyun Yong KOH, Dong Seok KIM
  • Publication number: 20200232039
    Abstract: The present invention relates to a composition for diagnosis or prognosis prediction of thyroid cancer, which includes an agent for measuring the expression level of mRNA of ADM2 gene or a protein thereof, a kit for diagnosis or prognosis prediction of thyroid cancer, which includes the composition, and a method for providing information for diagnosis or prognosis prediction of thyroid cancer using the composition or the kit.
    Type: Application
    Filed: June 19, 2019
    Publication date: July 23, 2020
    Inventors: Minho Shong, Yea Eun Kang, Jeong Ho Lee, Hyun Yong Koh, Hyun Jung Kim